LIN Form 4: Director Stephen Angel Exercises Options and Disposes Shares

Rhea-AI Filing Summary

Linde plc (LIN) director Stephen F. Angel reported option exercise and share sales on 08/07/2025. The filing shows the acquisition of 125,000 ordinary shares via exercise and contemporaneous dispositions of 74,691 and 50,309 shares at weighted average sale prices reported as $474.94 and $473.38, respectively. The exercise price reported for the transactions is $118.71. The Form 4 lists aggregate post-transaction beneficial ownership totals shown as 605,542.502 shares (direct) and additional indirect holdings held in descendants' trusts, a 401(k) account and deferred share units. The filing is signed by an attorney-in-fact on 08/08/2025.

Insights

Financial Analyst

TL;DR: Director exercised options for 125,000 shares and sold portions at about $474, showing routine tax/covering activity, not a material corporate change.

The Form 4 documents an option exercise resulting in 125,000 ordinary shares acquired at a reported exercise price of $118.71. The director sold 74,691 and 50,309 shares with weighted average sale prices of $474.94 and $473.38, respectively, and the filer explains shares were withheld to cover exercise price and tax withholdings. From an investor-impact perspective, these are insider liquidity and tax-related transactions rather than signals of corporate operational change; they do not alter outstanding option schedules or indicate new financing events.

Corporate Governance Expert

TL;DR: Routine director reporting: sizable option exercise, partial dispositions, and disclosure of indirect holdings and deferred units; governance controls appear followed.

The filing identifies Stephen F. Angel as a Director and discloses multiple forms of compensation-related holdings including restricted stock units, deferred stock units and several outstanding stock option grants with exercise and expiration details listed. The submission includes explicit explanations for withholding and sale price ranges and is signed by an attorney-in-fact, indicating adherence to reporting procedures. This disclosure is standard for compensatory equity activity and raises no governance red flags in the document itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANGEL STEPHEN F

(Last) (First) (Middle)

C/O LINDE PLC

FORGE, 43 CHURCH STREET WEST

(Street)

WOKING SURREY X0 GU216HT

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/07/2025		M		125,000	A	$118.71	605,542.502	D
Ordinary Shares	08/07/2025		F		74,691(1)	D	$474.94	530,851.502	D
Ordinary Shares	08/07/2025		S		50,309	D	$473.38(2)	480,542.502	D
Ordinary Shares								71,029	I	2010 Descendants Trust
Ordinary Shares								20,517	I	2012 Descendants Trust
Ordinary Shares								2,268	I	In trust for children
Ordinary Shares								11,152.107	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(3)							(3)	(3)	Ordinary Shares	1,023		1,029.658	D
Restricted Stock Units	(4)							(4)	(4)	Ordinary Shares	11,544.595		11,619.731	D
Restricted Stock Units	(5)							(5)	(5)	Ordinary Shares	11,439.057		11,513.507	D
Restricted Stock Units	(6)							(6)	(6)	Ordinary Shares	11,454.044		11,528.591	D
Restricted Stock Units	(7)							(7)	(7)	Ordinary Shares	24,267.709		24,425.651	D
Restricted Stock Units	(8)							(8)	(8)	Ordinary Shares	31,571.992		31,777.473	D
Restricted Stock Units	(9)							(9)	(9)	Ordinary Shares	46,158.508		46,458.924	D
Restricted Stock Units	(10)							(10)	(10)	Ordinary Shares	26,505.458		26,667.965	D
Stock Options (right to buy)	$253.68(11)							03/08/2022(11)	03/08/2031(11)	Ordinary Shares	133,465		133,465	D
Stock Options (right to buy)	$173.13(12)							03/09/2021(12)	03/09/2030(12)	Ordinary Shares	169,560		169,560	D
Stock Options (right to buy)	$176.63(13)							03/20/2020(13)	03/20/2029(13)	Ordinary Shares	177,605		177,605	D
Stock Options (right to buy)	$154(14)							02/27/2019(14)	02/27/2028(14)	Ordinary Shares	318,780		318,780	D
Stock Options (right to buy)	$118.71(15)	08/07/2025		M			125,000	02/28/2018(15)	02/28/2027	Ordinary Shares	125,000	$0	74,850	D
Deferred Stock Units	$0(16)							(17)	(17)	Ordinary Shares	109,094.189		109,094.189	D

Explanation of Responses:

1. Ordinary shares withheld to cover exercise price and tax withholdings.

2. The price reported is the weighted average sale price. The sale prices ranged from $471.39 to $474.62. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

3. The Restricted Stock Unit ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made.

4. Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

5. Restricted Stock Units that have vested in full but whose payout has been deferred to a future date.

6. Restricted Stock Units granted March 20, 2019, that have vested in full but whose payout has been deferred to a future date.

7. Restricted Stock Units granted February 27, 2018, that have vested in full but whose payout has been deferred to a future date.

8. Restricted Stock Unit award granted February 28, 2017, that has vested in full but whose payout has been deferred to a future date.

9. Restricted Stock Units granted February 28, 2017, that have vested in full but whose payout has been deferred to a future date.

10. Restricted Stock Unit award granted February 23, 2016, that has vested in full but whose payout has been deferred to a future date.

11. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

12. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

13. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.

14. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.

15. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.

16. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis

17. Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.

Remarks:

	Anthony M. Pepper as attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Linde (LIN) director Stephen F. Angel report on 08/07/2025?

The Form 4 reports an option exercise resulting in the acquisition of 125,000 ordinary shares and contemporaneous dispositions of 74,691 and 50,309 shares.

At what prices were shares sold in the LIN Form 4?

The filing reports weighted average sale prices of $474.94 and $473.38 for the reported dispositions; the range noted was $471.39 to $474.62.

What exercise price was reported for the option exercise in the LIN filing?

The exercise price reported for the transaction is $118.71.

How many shares did the reporting person beneficially own after the transactions?

The filing shows a post-transaction beneficial ownership figure of approximately 605,542.502 ordinary shares held directly, plus additional indirect holdings in trusts and deferred plans.

Who signed the Form 4 for Stephen F. Angel?

The Form 4 was signed by Anthony M. Pepper as attorney-in-fact on 08/08/2025.